The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients

被引:17
|
作者
Hiroki Nishikawa
Eriko Iguchi
Yorimitsu Koshikawa
Soichiro Ako
Tadashi Inuzuka
Haruhiko Takeda
Jun Nakajima
Fumihiro Matsuda
Azusa Sakamoto
Sinichiro Henmi
Keiichi Hatamaru
Tetsuro Ishikawa
Sumio Saito
Ryuichi Kita
Toru Kimura
Yukio Osaki
机构
[1] Osaka Red Cross Hospital,Department of Gastroenterology and Hepatology
[2] Osaka Red Cross Hospital,Department of Gastroenterology and Hepatology
关键词
Chronic hepatitis C; Pegylated interferon; Ribavirin; Treatment response; Elderly patients;
D O I
10.1186/1756-0500-5-135
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection
    Takayama, Tetsuro
    Ebinuma, Hirotoshi
    Tada, Shinichiro
    Yamagishi, Yoshiyuki
    Wakabayashi, Kanji
    Ojiro, Keisuke
    Kanai, Takanori
    Saito, Hidetsugu
    Hibi, Toshifumi
    [J]. PLOS ONE, 2011, 6 (12):
  • [2] Antiviral/Immunomodulatory Combination Therapy: Pegylated Interferon Alpha 2a and Ribavirin in Patients with Chronic Hepatitis C Virus Infection
    Delic, Dragan
    Mitrovic, Nikola
    Popovic, Natasa
    Urosevic, Aleksandar
    Pesic, Ivana
    Simonovic, Jasmina
    Dulovic, Olga
    Svirtlih, Neda
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2012, 140 (9-10) : 612 - 618
  • [3] Effect of combination therapy of interferon alpha and ribavirin in the patients with chronic hepatitis C
    Kim, Seok Hyn
    Lee, Byung Seok
    Lee, Heon Young
    Lee, Tae Hee
    Kang, Young Woo
    Park, Jeong Hoon
    Kim, Hong Su
    Kim, Suk Bae
    Song, Il Han
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A467 - A467
  • [4] Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT
    Al-Ali, Jaber
    Siddique, Iqbal
    Varghese, Rosh
    Hasan, Fuad
    [J]. ANNALS OF HEPATOLOGY, 2012, 11 (02) : 186 - 193
  • [5] Therapy Induced Anemia in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon Alpha and Ribavirin
    Mehdi, Syed Ghazanfar
    Faizi, Karim Shah
    Khan, Rao Saad Ali
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (01): : 204 - 206
  • [6] Prediction of sustained virologic responses to combination therapy of pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C infection
    Ismail, Mona H.
    [J]. JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2013, 20 (01): : 35 - 40
  • [7] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    [J]. GUT, 2003, 52 (10) : 1532 - 1532
  • [8] Retreatment with pegylated interferon-alpha2b plus ribavirin in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interfermis combined with ribavirin
    Teuber, G
    Kallinowski, B
    Niederau, C
    Klinker, H
    Galle, PR
    Zankel, M
    Zeuzem, S
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A768 - A768
  • [9] Incidence of retinopathy in chronic Hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
    Kashif, Muhammad
    Saleem, Muhammad Khurram
    Farooka, Imran Khan
    Husnain, Amino
    Siddiqui, Arif Mahmood
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (01) : 174 - 177
  • [10] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263